Pay in 4 interest-free payments of $23.75 Learn more
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
PQR-309 also inhibits PI3Kα-H1047R)
MCT-14-1077
Sotagliflozin
Migration of T cells on surfaces containing complex nanotopography
the resulting complex becomes activated and binds to specific sites on DNA
GSK-1070916 Catalog No.:M10968-10 PQR-309 also inhibits PI3Kα-H1047R)GSK1070916, also known as NMI 900 or GSK 1070916A, is an ATP competitive inhibitor of the serine threonine kinases Aurora B and C with potential antineoplastic activity. Aurora B C kinase inhibitor GSK1070916A binds to and inhibits the activity of Aurora kinases B and C, which may result in inhibition of cellular division and a decrease in the proliferation of tumor cells that overexpress the Aurora kinases B and C. Product information CAS Number:
US$ 18500.00
US$ 5750.00
US$ 42.00
US$ 3899.50
US$ 15950.00
US$ 18449.50
US$ 4099.50
US$ 6625.00
US$ 13500.00
US$ 5299.50
US$ 2149.50
US$ 6500.00
US$ 8999.50
US$ 3149.50
US$ 12499.50